Sionna revives AbbVie’s cystic fibrosis drugs, eyeing a shot at Vertex

Biotechnology startup Sionna Therapeutics has licensed a group of experimental cystic fibrosis drugs from AbbVie, planning to test them in combination regimens that could challenge Vertex Pharmaceuticals’ market-leading medicines.